CDKN2 (MTS1/p16INK4A) gene alterations in adult T-cell leukemia/lymphoma

Leukemia & Lymphoma
T UchidaT Hotta

Abstract

p16INK4A is a cyclin-dependent kinase inhibitor (CDKI), and regulates the cell cycle negatively. Recently, p16INK4A protein was shown to be encoded by the CDKN2 gene, which is identical to multiple tumor suppressor gene 1 (MTS1) on chromosome 9p21, where genetic alterations occur frequently in many malignant tumors. As the loss of p16INK4A function by genetic alterations leads to inappropriate progression of the cell cycle, the CDKN2 gene has been investigated intensively as a new candidate tumor suppressor gene in many malignant tumors. Adult T-cell leukemia/lymphoma (ATLL) is a peripheral T-cell malignancy associated with human T-cell lymphotrophic virus type 1 (HTLV-1). As the development to ATL is believed to require not only HTLV-1 infection but also accumulation of genetic alterations, we investigated the relationship between alterations in the CDKN2 gene and ATL. Alterations in the CDKN2 gene were detected in approximately 15 to 20% of ATL patients. Interestingly, most of the patients with CDKN2 gene alterations had the aggressive form of ATL. The CDKN2 gene appears to be the major tumor suppressor gene on chromosome 9p21, and alteration in this gene may play an important role during late stages in the transformation pro...Continue Reading

References

Jul 10, 1992·Cell·A Bird
Mar 1, 1989·Japanese Journal of Cancer Research : Gann·T OkamotoK Shimotohno
Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·R Dalla-FaveraC M Croce
Mar 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·M YoshidaY Hinuma
May 15, 1995·Genes & Development·C J Sherr, J M Roberts
Feb 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·W J GrossmanL Ratner
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·J G HermanW M Linehan
Jul 15, 1994·Science·P CairnsD Sidransky
Sep 1, 1996·British Journal of Haematology·T UchidaT Hotta
Feb 1, 1997·Leukemia & Lymphoma·T UchidaT Hotta

❮ Previous
Next ❯

Citations

Aug 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·W JiangM L Kripke
Oct 3, 1999·Current Opinion in Oncology·E Cesarman, E A Mesri
Jul 15, 2015·Journal of Oncology·Christophe Nicot
May 4, 2000·The American Journal of Pathology·I C NavasP Algara
Jul 11, 2020·Pathogens·Suchitra Mohanty, Edward W Harhaj

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.